Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank70
5Y CAGR-70.7%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
-70.7%/yr
Long-term compound
Percentile
P70
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 2.07% |
| Q3 2025 | 0.16% |
| Q2 2025 | -9.79% |
| Q1 2025 | 49.48% |
| Q4 2024 | -5.89% |
| Q3 2024 | -7.22% |
| Q2 2024 | -14.46% |
| Q1 2024 | 26.43% |
| Q4 2023 | -11.62% |
| Q3 2023 | 26.65% |
| Q2 2023 | -15.04% |
| Q1 2023 | -13.67% |
| Q4 2022 | -1.16% |
| Q3 2022 | -16.52% |
| Q2 2022 | 26.36% |
| Q1 2022 | -10.85% |
| Q4 2021 | -6.89% |
| Q3 2021 | -7.31% |
| Q2 2021 | 3.92% |
| Q1 2021 | 10.36% |
| Q4 2020 | 959.03% |
| Q3 2020 | -119.78% |
| Q2 2020 | 0.00% |
| Q1 2020 | 100.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |